LOG IN

Clinical Trial open to United Rheumatology Members

Clinical Trial open to United Rheumatology Members

Clinical Trial open to United Rheumatology Members

Beginning in June, Scipher Medicine will begin enrolling UR member sites for a trial called  NETWORK-004: A Prospective Observational Trial to Validate the Ability of PrismRA to Predict Non-Responders to anti-TNF Therapies. The primary endpoint of this study is the predictive ability of the PrismRA response classifier to identify anti-TNF therapy non-responders in female and/or all rheumatoid arthritis patients with moderate or high disease activity, using standard clinical outcome measures (CDAI, ACR50,DAS-28). The trial will serve as a lead-in to a prospective, randomized, interventional trial (NETWORK-001) Scipher will aim to kick off by year-end.

Learn More About How United Rheumatology Can Support You

Join Max Hamburger, M.D., Founder and Executive Chairman,United Rheumatology and the Clinical Operations team from Scipher Medicine for a 45-minute webinar. Participants will learn more about the clinical trial, enrollment, patient identification and selection process. Members can register via the link located in the sidebar.